modakafusp alfa,bortezomib
takeda
['fil,veral,12', 'modakafusp', 'mmsm']
#ash22| dan vogl presents results from the first-in-human phase 1/2 study of modakafusp alfa in pts with r/r mm. encouraging therapeutic activity was seen at 1.5mg/kg qw4 and a phase 2 trial to define single agent dosing is currently enrolling #mmsm #medicalcongress 
The Multiple Myeloma (MM) Hub is an online educational resource run in collaboration with the European School of Haematology @ESHaematology #mmsm #myeloma